Biogen Alzheimer’s drug could get Medicare coverage in 2025 if approved, says Dr. Scott Gottlieb

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins ‘Squawk Box’ to discuss if Biogen’s drug is tackling the root cause of Alzheimer’s, what scientists are learning from Biogen’s Alzheimer’s treatment and more.